Global Medical Blood Products Market Growth 2024-2030

Global Medical Blood Products Market Growth 2024-2030

Medical blood products refer to biological products used for treatment that are separated from healthy human plasma or plasma of specific immune populations using biological processes or separation and purification technologies. These products mainly include human albumin, human immunoglobulin, rabies immunoglobulin, human coagulation factors, etc. They play an important role in critical care, rescue, certain specific diseases and other fields, and are indispensable and important resources in the medical field.

In recent years, the scale of China's blood products market has continued to expand. In 2024, the scale of China's blood products market is expected to reach 59.64 billion yuan, a significant year-on-year increase. This growth trend is mainly due to the improvement of medical standards, the increase in per capita disposable income, and the wide application of blood products in the treatment of various diseases.

At the same time, the market demand for the blood products industry continues to grow, mainly driven by multiple factors such as the aging of the population, the advancement of medical technology, and the improvement of public health awareness. In particular, with the arrival of an aging society and the increase in the incidence of chronic diseases, the market demand for blood products will continue to grow.

The global Medical Blood Products market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Medical Blood Products Industry Forecast” looks at past sales and reviews total world Medical Blood Products sales in 2023, providing a comprehensive analysis by region and market sector of projected Medical Blood Products sales for 2024 through 2030. With Medical Blood Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Blood Products industry.

This Insight Report provides a comprehensive analysis of the global Medical Blood Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Blood Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Blood Products market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Blood Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Blood Products.

United States market for Medical Blood Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Medical Blood Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Medical Blood Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Medical Blood Products players cover Takeda, CSL, Grifols, Octapharma, Kedrion, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Blood Products market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Whole Blood And Blood Components
Plasma Products
Protein Products
Coagulation Factor Products
Other Blood Products

Segmentation by Application:
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
China Biologic Products Holdings
HUALAN BIOLOGICAL ENGINEERING
Beijing Tiantan Biological Products
China Resources Boya Bio-pharmaceutical Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Blood Products market?

What factors are driving Medical Blood Products market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Blood Products market opportunities vary by end market size?

How does Medical Blood Products break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.